Philip J. Koo, MD, discusses PSMA PET and how it is poised to supplant conventional imaging techniques in the diagnosis of prostate cancer. PSMA PET is also more effective in identifying lesions than using PET with fluciclovine, however, there is a threshold below which it cannot detect disease...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.